A good example is patatin-like phospholipase domain-containing protein 3 (PNPLA3) genetic testing for NAFLD susceptibility and hereditary hepatic disease, which is used clinically in Europe and the US. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.